ruthenium has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acco, A; Alves de Souza, CE; Alves de Souza, HM; Cardoso, CR; Carlos, RM; Correia Cadena, SMS; Corso, CR; de Souza Ramos, EA; Dittrich, RL; Galindo, CM; Klassen, G; Stipp, MC | 1 |
| Gruia, I; Gruia, MI; Negoita, V; Panait, M; Uivarosi, V; Vasilescu, M; Velescu, BS | 1 |
2 other study(ies) available for ruthenium and Carcinoma 256, Walker
| Article | Year |
|---|---|
Ruthenium complex exerts antineoplastic effects that are mediated by oxidative stress without inducing toxicity in Walker-256 tumor-bearing rats.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma 256, Walker; Caspase 3; Cell Respiration; Cell Survival; Coordination Complexes; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Injections, Subcutaneous; Male; Necrosis; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reactive Oxygen Species; Ruthenium; Tumor Burden; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2017 |
Biochemical action of new complexes of ruthenium with quinolones as potential antitumor agents.
Topics: Animals; Apoptosis; Carcinoma 256, Walker; Flow Cytometry; Humans; Quinolones; Rats; Reactive Oxygen Species; Ruthenium; Signal Transduction | 2015 |